Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis.
OBJECTIVE
Endomysial autoantibodies (EmA) are specific for celiac disease. The target antigen has been identified as tissue tranglutaminase (tTG). Our aim was to study the accuracy of a newly developed enzyme-linked immunosorbent assay (ELISA) for easy detection of tTG autoantibodies.


METHODS
Thirty-one sera from patients with histologically proven celiac disease and 23 healthy controls were examined for EmA using monkey esophagus and human umbilical cord as substrate. IgA-tTG autoantibodies were determined by newly developed ELISA. Additionally, sera from patients with dermatitis herpetiformis (n = 20), inflammatory bowel disease (IBD; n = 32), chronic liver disease (n = 36), and diabetes mellitus (n = 19) were tested.


RESULTS
The sensitivity of the tTG autoantibody ELISA accounted for 90% detection in patients with untreated celiac disease. The specificity was 76% owing to positive values in the lower range in patients with IBD (15%), chronic liver disease (36%), and diabetes (22%), all of whom were negative for EmA. In dermatitis herpetiformis patients 90% were EmA-positive. Of these, only 47% showed elevated tTG autoantibodies. Preincubation of sera from dermatitis patients with tTG abolished immunofluorescent staining of endomysial structures.


CONCLUSIONS
Detection of mid- to high-titer tTG autoantibodies is highly specific for celiac disease. However, in the low-titer range, overlap exists with liver disease, IBD, and diabetes. Tissue transglutaminase autoantibodies may evolve as a new screening and follow-up method for celiac disease. Although tTG seems to be a major autoantigen in dermatitis herpetiformis, the low sensitivity of both tTG ELISA and immunofluorescence using human umbilical cord suggests differential involvement of tTG in this disease.
Koop
I
I
Department of Internal Medicine, Charité, Humboldt-University, Berlin.
Ilchmann
R
R
Izzi
L
L
Adragna
A
A
Koop
H
H
Barthelmes
H
H
D000818:Animals; D001323:Autoantibodies / Q000032:analysis*; D002446:Celiac Disease / Q000276:immunology*; D003874:Dermatitis Herpetiformis / Q000276:immunology*; D004797:Enzyme-Linked Immunosorbent Assay; D004947:Esophagus / Q000276:immunology; D005455:Fluorescent Antibody Technique; D000882:Haplorhini / Q000276:immunology; D006801:Humans; D066298:In Vitro Techniques; D012680:Sensitivity and Specificity; D011503:Transglutaminases / Q000276:immunology*; D014470:Umbilical Cord / Q000276:immunology
D001323:Autoantibodies; D011503:Transglutaminases